Join the Parkinson's Disease Psychosis group to help and get support from people like you.
Parkinson's Disease Psychosis News (Page 2)
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
WEDNESDAY, Sept. 18, 2024 – For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and Parkinson disease...
Upper GI Mucosal Damage Tied to Later Parkinson Disease Diagnosis
WEDNESDAY, Sept. 11, 2024 – A history of upper gastrointestinal mucosal damage (MD) is associated with a higher subsequent risk for developing Parkinson disease (PD), according to a study published...
Fecal Microbiota Transplant No Aid for Parkinson Disease
FRIDAY, Aug. 2, 2024 – Fecal microbiota transplantation (FMT) is safe but does not offer clinically meaningful improvements for Parkinson disease (PD), according to a study published online July 29...
Retired Rugby Players Face Risks for Dementia, CTE
THURSDAY, July 18, 2024 – Alix Popham played in two rugby World Cups and won a Six Nations Grand Slam before retiring in 2011 as a professional in the rough-and-tumble game. By 2020, he had already...
Structure, Function of Brain Connectome Tied to Gray Matter Atrophy in Parkinson Disease
MONDAY, July 8, 2024 – For patients with mild Parkinson disease (PD), the structural and functional architecture of the brain connectome is associated with progression of gray matter (GM) atrophy,...
Anxiety Tied to Doubling of Parkinson's Risk
WEDNESDAY, June 26, 2024 – Anxiety could be an early warning sign of Parkinson's disease, a new study finds. People with anxiety have at least double the risk of developing Parkinson’s compared to t...
Smartwatch, Smartphone Can Assess Parkinson Disease Progression
MONDAY, June 24, 2024 – Gait and tremor measures derived from a commercially available smartwatch and smartphone could help evaluate the efficacy of therapies for Parkinson disease (PD), according...
Acadia Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for Nuplazid (pimavanserin)
SAN DIEGO--(BUSINESS WIRE)--Jun. 29, 2018-- Acadia Pharmaceuticals Inc. today announced FDA approval of a new capsule dose formulation and a new tablet strength of Nuplazid (pimavanserin) to help in...